US Stock MarketDetailed Quotes

RVLPQ RVL Pharmaceuticals

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose May 10 16:00 ET
111.41Market Cap0.00P/E (TTM)

RVL Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RVL Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2023 Earnings

--

Revenue(YoY)

8.26M

-2.25%
EPS(YoY)

-0.24

-71.43%
Analyst Rating

No Data

RVL Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q28.258M / 10.254M--
--2023/Q18.832M / 9.197M--
--2022/Q49.807M / 12.730M--
--2022/Q310.022M / 10.028M--
--2022/Q28.448M / 8.519M--
--2022/Q121.444M / 6.800M--
--2021/Q42.860M / 3.102M--
--2021/Q32.196M / 2.358M--
--2021/Q234.799M / 34.550M--
--2021/Q123.880M / 30.650M--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q28.258M / 10.254M--
--2023/Q18.832M / 9.197M--
--2022/Q49.807M / 12.730M--
--2022/Q310.022M / 10.028M--
--2022/Q28.448M / 8.519M--
--2022/Q121.444M / 6.800M--
--2021/Q42.860M / 3.102M--
--2021/Q32.196M / 2.358M--
--2021/Q234.799M / 34.550M--
--2021/Q123.880M / 30.650M--

Unlock Free Earnings Estimates

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg